The atopic dermatitis market
| Autor: | Eleni Pantazi, Gianluca Valenza, Bashar Hamad, Manuela Hess |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
0301 basic medicine
Pharmacology medicine.medical_specialty Drug Industry 030102 biochemistry & molecular biology business.industry MEDLINE Crisaborole General Medicine Atopic dermatitis medicine.disease Dermatology Dupilumab Dermatitis Atopic body regions 03 medical and health sciences Pharmaceutical Preparations Drug Discovery Humans Medicine sense organs skin and connective tissue diseases business |
| Zdroj: | Nature Reviews Drug Discovery. 17:237-238 |
| ISSN: | 1474-1784 1474-1776 |
| DOI: | 10.1038/nrd.2017.192 |
| Popis: | The market for atopic dermatitis therapies is dominated by topical corticosteroids, but is poised to change with the recent approvals of dupilumab and crisaborole, as well as other drugs in clinical development. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink